Lobbying client · LD-2 disclosures
Lyndra Therapeutics
Massachusetts
25 filings from 2 registrants · 2019–2023 · latest filed Mar 8, 2023
Reported on its behalf
$1.1M
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$1.1M
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
21 filings
$1.1M on those filings
Defense
DEF
7 filings
$335K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
Who did the lobbying
Every lobbyist named on this client's filings.
- James L Ervin Ervin Graves Strategy Group, LLC14 filingsthrough 2022
- Colby Miller Ervin Graves Strategy Group, LLCCovered position: former Congressional staffer14 filingsthrough 2022
- John Blount Ervin Graves Strategy Group, LLC11 filingsthrough 2021
- Robert Wood Bgr Government AffairsCovered position: See prior filing9 filingsthrough 2022
- Brent Alan Del Monte
The filings
The 20 most recent of 25 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: lyndra-therapeutics.